Trade Madrigal Pharmaceuticals, Inc. - MDGL CFD
What is Madrigal Pharmaceuticals, Inc. (MDGL)?
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company specializing in the development of novel therapies for cardiovascular, metabolic, and liver diseases. The company focuses on advancing small molecule drugs that target mitochondrial function and metabolic pathways. Its research and development efforts aim to address conditions such as nonalcoholic steatohepatitis (NASH) and other metabolic disorders. Madrigal employs a pipeline approach to drug development, advancing candidates through clinical trials to evaluate safety and efficacy. The company operates within the broader pharmaceutical industry and collaborates with academic and research institutions to support its scientific initiatives.
Madrigal Pharmaceuticals, Inc. Stock Price Today: Live Overview
The price today is shaped by current market dynamics, as Madrigal Pharmaceuticals, Inc. trades at $527.53. Its intraday range spans from $522.53 to $536.5, showing a shift of +0.1335%.
FAQ: Madrigal Pharmaceuticals, Inc. (MDGL)
What is the current price of MDGL stock?
The current price is $527.53.
Does MDGL pay dividends?
The company does not pay dividends.
Does MDGL have a formal corporate presence or regional headquarters in the UAE?
Madrigal Pharmaceuticals, Inc. operates in the UAE only via partners and distributors.
What is MDGL best known for?
It is most famous for developing novel therapeutics for liver diseases.
What assets are typically shown together with MDGL?
Commonly shown alongside MDGL: Aristocrat Leisure, ASX Limited, Amundi Msci EM Latin America UCITS ETF
Latest shares articles
Ratings and Reviews
Ratings and Reviews
